Target intelligence / Profile preview

T cell receptor beta variable 25-1 (TRBV25-1)

Target
TRBV25-1
Molecular classification
Receptor, T cell receptor (Immunoglobulin superfamily, variable domain)
01

Overview

T cell receptor beta variable 25-1 is a protein domain encoded by the TRBV25-1 gene, representing the V (variable) segment of the beta chain of the alpha-beta T cell receptor complex. This segment contributes to the antigen-binding site of the TCR, conferring most of the receptor’s specificity to peptide-major histocompatibility (MHC) complexes displayed by antigen-presenting cells. The TRBV25-1 variable region is classically involved in the invariant natural killer T (iNKT) cell receptor, when paired with specific alpha-chain segments (notably TRAV10-TRAJ18 in humans). Its engagement triggers T cell activation and multiple signaling cascades (including MAPK, calcium, and NF-κB pathways) essential for immune responses, proliferation, and differentiation. The repertoire of TCRs using TRBV25-1 is shaped in the thymus and plays a key role in self-tolerance and adaptive immunity. As a variable segment, TRBV25-1 is primarily a structural and functional element of the TCR in a subset of T cells (not a standalone drug target), but may serve as a biomarker in studies of T cell subsets or immune repertoire analyses.

Other names
TRBV251TCRBV11S1A1TTCRBV25S1V_segment translation productTRBV25-1 (Gene symbol)TVBY1_HUMAN (UniProt entry)TRBV25-1 (HGNC: 12205, NCBI Gene: 28562, UniProtKB/Swiss-Prot: A0A075B6N4)
02

Mechanism of action

Not applicable for drugs directly, as there are no drugs that specifically act on TRBV25-1 as a molecular target. Any action would be indirect, by modulating T cell receptor signaling generally or targeting T cells expressing this receptor subtype.

03

Biological functions

Immune responseAntigen recognitionSignal transduction (via T cell receptor complex)
04

Disease associations

Cancer (implicated as component of the immune response in cancers)Infection (adaptive immunity against pathogens)Inflammation (T cell–mediated conditions)Other (autoimmunity, as part of TCR diversity shaping self-tolerance in thymus)
05

Safety considerations

Immunotoxicity (general for TCR-targeted therapies, e.g., cytokine release syndrome in engineered cell therapy contexts, but not specific to TRBV25-1 segment)Autoimmunity (theoretical, based on TCR diversity but not specific to TRBV25-1)
06

Interacting drugs

None known to target TRBV25-1 specifically. General T cell receptor modulators (e.g., TCR-mimetic antibodies, immune checkpoint inhibitors) might affect cells bearing this segment, but no drugs target this variable segment exclusively.
07

Biomarkers

Invariant NKT cell marker (when paired with TRAV10-TRAJ18, typical of type I NKT cells)Potential immune repertoire biomarker in contexts where variable segment usage is assessed (e.g., minimal residual disease, some hematologic malignancies, or immune monitoring)

Beyond the preview

Go deeper on T cell receptor beta variable 25-1 (TRBV25-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 25-1 (TRBV25-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call